BRIGATINIB

2567 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking BRIGATINIB:

# Side effect Count
0 DEATH 311
1 NON-SMALL CELL LUNG CANCER 298
2 OFF LABEL USE 193
3 DIARRHOEA 185
4 NEOPLASM PROGRESSION 172
5 NAUSEA 166
6 FATIGUE 153
7 METASTASES TO CENTRAL NERVOUS SYSTEM 153
8 BLOOD CREATINE PHOSPHOKINASE INCREASED 147
9 LUNG NEOPLASM MALIGNANT 144
See all common reactions for BRIGATINIB

BRIGATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-SMALL CELL LUNG CANCER 298 0.0803
1 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 4 0.0755
2 PITUITARY INFARCTION 3 0.0732
3 LUNG ADENOCARCINOMA STAGE IV 14 0.0495
4 ANTI FACTOR X ACTIVITY INCREASED 2 0.0465
5 PLEURODESIS 3 0.0345
6 ANAPLASTIC LARGE-CELL LYMPHOMA 6 0.0250
7 RADIATION NECROSIS 9 0.0234
8 NON-SMALL CELL LUNG CANCER METASTATIC 14 0.0225
9 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 10 0.0203
See all enriched reactions for BRIGATINIB